Tamoxifen Therapy for Retroperitoneal Fibrosis
Authors: Eric F.H. van Bommel, Tadek R. Hendriksz
Journal: Annals of Internal Medicine (2006)

Letters18 April 2006Tamoxifen Therapy for Retroperitoneal FibrosisEric F.H. van Bommel, MD, PhD and Tadek R. Hendriksz, MDEric F.H. van Bommel, MD, PhDFrom Albert Schweitzer Hospital, NL-3300 AK Dordrecht, the Netherlands. and Tadek R. Hendriksz, MDFrom Albert Schweitzer Hospital, NL-3300 AK Dordrecht, the Netherlands.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-144-8-200604180-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We agree with Drs. Vaglio, Greco, and Buzio that standardized classification criteria for RPF are lacking. However, our own experience and interpretation of the literature led us to believe that, in a subset of patients with presumed idiopathic disease, the condition is actually a local complication of advanced atherosclerosis (1). The higher incidence of symptomatic atherosclerotic disease in men may also explain the increased incidence of RPF in men. Some researchers even suggest that the future of this disorder lies in the prevention and treatment of atherosclerosis (2). Consequently, the proposed term chronic periaortitis (encompassing patients with and ...References1. van Bommel EF. Retroperitoneal fibrosis. Neth J Med. 2002;60:231-42. [PMID: 12365466] MedlineGoogle Scholar2. Baker LR. Auto-allergic periaortitis (idiopathic retroperitoneal fibrosis). BJU Int. 2003;92:663-5. [PMID: 14616440] CrossrefMedlineGoogle Scholar3. Parums DV. The spectrum of chronic periaortitis. Histopathology. 1990;16:423-31. [PMID: 2193863] CrossrefMedlineGoogle Scholar4. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141:764-70. [PMID: 15545676] LinkGoogle Scholar5. Grainger DJ, Schofield PM. Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence. Circulation. 2005;112:3018-24. [PMID: 16275887] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Eric F.H. van Bommel, MD, PhD; Tadek R. Hendriksz, MDAffiliations: From Albert Schweitzer Hospital, NL-3300 AK Dordrecht, the Netherlands.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoTaking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease Li Wei , Thomas M. MacDonald , and Brian R. Walker Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis Eric F.H. van Bommel , Tadek R. Hendriksz , Antonius W.L.C. Huiskes , and Antoine G.M. Zeegers Tamoxifen Therapy for Retroperitoneal Fibrosis Augusto Vaglio , Paolo Greco , and Carlo Buzio Metrics Cited byPersistent chronic peri-aortitis ('inflammatory aneurysm') after abdominal aortic aneurysm repair: systematic review of the literature 18 April 2006Volume 144, Issue 8 Page: 619-620 Keywords Atherosclerosis Cholesterol Conflicts of interest Corticosteroid therapy Fibrosis Forecasting Immunosuppressives Morbidity Renal failure Vascular diseases ePublished: 18 April 2006 Issue Published: 18 April 2006 Copyright & PermissionsCopyright © 2006 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...